High Disease Perception in Brain Predicts TNF Inhibitor Response in Rheumatoid Arthritis
Research published in The Lancet Rheumatology reveals that high central nervous system pain activation, measured by functional MRI, predicts treatment response to TNF inhibitors in patients with rheumatoid arthritis.
This study addresses a new concept of RA, as it shows that patients with high disease perception in the brain are more likely to respond to treatment with TNF inhibition
According to Georg Schett, MD, of Friedrich-Alexander University Erlangen-Nürnberg, in Germany, this study introduces a new concept in rheumatoid arthritis treatment.
- High central nervous system pain activation predicts treatment response to TNF inhibitors.
- Functional MRI measures pain activation in patients with rheumatoid arthritis.
Author's summary: High brain disease perception predicts TNF inhibitor response.
More News
- A Conference of Metamorphosis — Art+ Magazine
- Wiregrass talent shines in Deep South’s oldest rivalry
- NYT Connections Hints Today, October 14, 2025: See Today’s Word List And Helpful Clues | Herzindagi
- Nuno Espirito Santo has finetuned new tactical plan during international break that will guarantee West Ham survival
- Cheryl's shock call to Liam Payne's girlfriend
- Sydney to Auckland Ocean Race Day 4 - Lucky claims line honours but race still on
- Commentary: UK opens ISAs to crypto – is it too little, too late? | University of Surrey
- Class Action Alleges Microsoft Choked AI Supply to Lift ChatGPT Costs - Decrypt
- Alec Baldwin reassures fans after crashing car into ‘big fat tree’
- 'Helicopters may soon be banned from cruise ships in Antarctica', warns Polar Latitude Expeditions boss